BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Alzheimer’s Research Shifts from Amyloid and Tau to Neuroinflammation, Other Causes

  Research into Alzheimer’s disease is shifting from amyloid plaque and tau protein to neuroinflammation, white matter changes and insulin resistance.

  November 8, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Exploring the Mystery of COVID-19 Vaccine-Linked Heart Inflammation (Myocarditis Symptoms)

  Researchers aren’t sure why the mRNA vaccines appear to cause myocarditis symptoms. The FDA said the risk appears more after the second dose. Find more here.

  November 8, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Blackstone Commits $250 Million to Help Autolus Vanquish Leukemia

  Autolus is currently working on advancing obecabtagene autoleucel, its CD19 CAR T cell investigational therapy product candidate, in addition to other applications of obe-cel in B-cell malignancies.

  November 8, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  GSK Presents Optimistic CKD-Related Anemia Results Months After Rivals’ Failure

  GlaxoSmithKline is lining up a potential new treatment for patients with anemia due to chronic kidney disease following positive results in a Phase III study.

  November 8, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Why Flu Vaccines are Recommended Despite Low Efficacy

  While some get the jab faithfully each flu season, about half of the American population declines, likely over doubts of the vaccine’s effectiveness and necessity.

  November 8, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Bristol Myers’ Opdivo Delivers Increased Survival in NSCLC

  Bristol Myers Squibb’s Phase III CheckMate -816 trial hit the primary endpoint in an interim analysis.

  November 8, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  New Results Reinforce REGEN-COV’s Strength in Preventing COVID-19

  Regeneron Pharmaceuticals announced more positive findings from its ongoing Phase III trial on the use of REGEN-COV to prevent COVID-19 in uninfected persons who have been exposed to the virus.

  November 8, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Deals

  Blade Therapeutics Eyes Nasdaq in 2022 with Planned SPAC Merger

  The merger between Blade Therapeutics and Biotech Acquisition Company will provide the company with $254.3 million to drive the development of cudetaxestat.

  November 8, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Career Advice

  How to Find the Right Career Path in the Pharma Industry

  Trying to develop a career in pharma may be overwhelming when you think about it. However, this article can help!

  November 8, 2021

   · 

  5 min read

   · 

  Alina Zahid
• 

  Business

  Flagship Debuts Alltrna to Unlock the Mysteries of tRNA

  Alltrna, based in Cambridge, Mass. near its cousin Moderna, debuts as the first platform transfer RNA (tRNA) company.

  November 8, 2021

   · 

  3 min read

   · 

  Heather McKenzie